Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Serum Lipoproteins
100%
Multi-Ethnic Study of Atherosclerosis
100%
Liver
20%
Spleen
20%
Atherogenic Dyslipidemia
20%
High-density Lipoprotein Cholesterol (HDL-C)
20%
LDL Particle Size
20%
Metabolic Risk Factors
20%
Particle Concentration
20%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
20%
Dose Effect
10%
Low-density Lipoprotein Cholesterol (LDL-C)
10%
Cardiovascular Disease
10%
Cholesterol Levels
10%
Insulin Resistance
10%
Pathophysiologic
10%
Dyslipidemia
10%
Low Serum
10%
Metabolic Syndrome
10%
Adiposity
10%
Risk Measures
10%
Non-contrast
10%
Serum HDL
10%
Serum Triglycerides
10%
Cardiac Computed Tomography
10%
Atherogenic Lipoproteins
10%
Lipoprotein Particles
10%
Lipoprotein Abnormalities
10%
Lipoprotein Particle Size
10%
Multiple Measures
10%
Population-based Prospective Cohort Study
10%
Attenuation Ratio
10%
Medicine and Dentistry
Lipoprotein
100%
Atherosclerosis
100%
Nonalcoholic Fatty Liver
100%
Dyslipidemia
30%
Homeostatic Model Assessment
20%
Cardiovascular Disease
10%
Prospective Cohort Study
10%
Insulin Resistance
10%
Metabolic Syndrome
10%
Triacylglycerol
10%
X-Ray Computed Tomography
10%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Atherosclerosis
100%
Lipoprotein
100%
Dyslipidemia
30%
Cardiovascular Disease
10%
Triacylglycerol
10%
Insulin Resistance
10%
Metabolic Syndrome X
10%
Prospective Cohort Study
10%